2012年ADA糖尿病诊疗标准版

2012-06-19 佚名 中华医学会糖尿病学分会

  糖尿病是一种慢性疾病,需要持续的治疗、不断的患者自我管理教育和预防急性并发症及降低长期并发症的风险。糖尿病治疗是复杂的,需要解决控制血糖之外的很多问题。大量的证据支持,一定的干预措施可改善糖尿病的结果。   本标准由糖尿病治疗、治疗目标和治疗质量评估工具组成,与临床医生、患者、研究人员、付款人和其他感兴趣的人分享,其中,各项指标适用于大多数糖尿病患者,但须根据患者的个体偏好、合并症以及其他因

  糖尿病是一种慢性疾病,需要持续的治疗、不断的患者自我管理教育和预防急性并发症及降低长期并发症的风险。糖尿病治疗是复杂的,需要解决控制血糖之外的很多问题。大量的证据支持,一定的干预措施可改善糖尿病的结果。

  本标准由糖尿病治疗、治疗目标和治疗质量评估工具组成,与临床医生、患者、研究人员、付款人和其他感兴趣的人分享,其中,各项指标适用于大多数糖尿病患者,但须根据患者的个体偏好、合并症以及其他因素调整目标。标准中特设儿童、孕妇和糖尿病前期等章节。本标准并不妨碍其他专家视需要作出临床判断或延伸患者评价和管理。糖尿病管理的更详细的信息见参考文献1~3。

  “建议”部分包括对糖尿病患者健康状况已知或确信产生有利影响的筛查、诊断和医疗行为。这种措施的许多是划算的[4]。本协会仿照现有方法制订了分级体系见表(1),用来阐明和编纂各项建议的证据。支持各项建议的证据等级使用字母A、B、C或E列于每项建议之后。

   每年,本协会多学科专业执业委员会纳入新的证据,修订本标准。此次修订,委员会成员系统地搜索了自2010年1月1日出版的美国国立医学图书馆的国际性综合生物医学信息书目数据库(Medline)中关于人类研究的章节。根据新的证据,修订了建议(在每节的开头),或在某些情况下澄清了以前的建议,或按证据要点进行了措辞。连接建议变化新证据的表见http://professional.diabetes.org/CPR_Sear ch.aspx。随后,本标准经过了包括医疗保健专家、科学家和非专业人士的ADA董事会执行委员会的审查和批准。

  点击这里下载 ADA2012糖尿病诊疗标准.pdf    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1749199, encodeId=e9b91e49199be, content=<a href='/topic/show?id=42d8e678554' target=_blank style='color:#2F92EE;'>#糖尿病诊疗标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76785, encryptionId=42d8e678554, topicName=糖尿病诊疗标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fec336244124, createdName=xzw125, createdTime=Mon Dec 03 16:11:00 CST 2012, time=2012-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024648, encodeId=682f2024648fd, content=<a href='/topic/show?id=4c071955e4' target=_blank style='color:#2F92EE;'>#ADA糖尿病诊疗标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1955, encryptionId=4c071955e4, topicName=ADA糖尿病诊疗标准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Fri Aug 10 23:11:00 CST 2012, time=2012-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1954746, encodeId=f5011954e4636, content=<a href='/topic/show?id=391b91e0533' target=_blank style='color:#2F92EE;'>#诊疗标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91705, encryptionId=391b91e0533, topicName=诊疗标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon Aug 06 22:11:00 CST 2012, time=2012-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264444, encodeId=1d811264444f9, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Thu Jun 21 10:11:00 CST 2012, time=2012-06-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1749199, encodeId=e9b91e49199be, content=<a href='/topic/show?id=42d8e678554' target=_blank style='color:#2F92EE;'>#糖尿病诊疗标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76785, encryptionId=42d8e678554, topicName=糖尿病诊疗标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fec336244124, createdName=xzw125, createdTime=Mon Dec 03 16:11:00 CST 2012, time=2012-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024648, encodeId=682f2024648fd, content=<a href='/topic/show?id=4c071955e4' target=_blank style='color:#2F92EE;'>#ADA糖尿病诊疗标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1955, encryptionId=4c071955e4, topicName=ADA糖尿病诊疗标准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Fri Aug 10 23:11:00 CST 2012, time=2012-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1954746, encodeId=f5011954e4636, content=<a href='/topic/show?id=391b91e0533' target=_blank style='color:#2F92EE;'>#诊疗标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91705, encryptionId=391b91e0533, topicName=诊疗标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon Aug 06 22:11:00 CST 2012, time=2012-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264444, encodeId=1d811264444f9, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Thu Jun 21 10:11:00 CST 2012, time=2012-06-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1749199, encodeId=e9b91e49199be, content=<a href='/topic/show?id=42d8e678554' target=_blank style='color:#2F92EE;'>#糖尿病诊疗标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76785, encryptionId=42d8e678554, topicName=糖尿病诊疗标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fec336244124, createdName=xzw125, createdTime=Mon Dec 03 16:11:00 CST 2012, time=2012-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024648, encodeId=682f2024648fd, content=<a href='/topic/show?id=4c071955e4' target=_blank style='color:#2F92EE;'>#ADA糖尿病诊疗标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1955, encryptionId=4c071955e4, topicName=ADA糖尿病诊疗标准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Fri Aug 10 23:11:00 CST 2012, time=2012-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1954746, encodeId=f5011954e4636, content=<a href='/topic/show?id=391b91e0533' target=_blank style='color:#2F92EE;'>#诊疗标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91705, encryptionId=391b91e0533, topicName=诊疗标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon Aug 06 22:11:00 CST 2012, time=2012-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264444, encodeId=1d811264444f9, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Thu Jun 21 10:11:00 CST 2012, time=2012-06-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1749199, encodeId=e9b91e49199be, content=<a href='/topic/show?id=42d8e678554' target=_blank style='color:#2F92EE;'>#糖尿病诊疗标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76785, encryptionId=42d8e678554, topicName=糖尿病诊疗标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fec336244124, createdName=xzw125, createdTime=Mon Dec 03 16:11:00 CST 2012, time=2012-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024648, encodeId=682f2024648fd, content=<a href='/topic/show?id=4c071955e4' target=_blank style='color:#2F92EE;'>#ADA糖尿病诊疗标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1955, encryptionId=4c071955e4, topicName=ADA糖尿病诊疗标准)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Fri Aug 10 23:11:00 CST 2012, time=2012-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1954746, encodeId=f5011954e4636, content=<a href='/topic/show?id=391b91e0533' target=_blank style='color:#2F92EE;'>#诊疗标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91705, encryptionId=391b91e0533, topicName=诊疗标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Mon Aug 06 22:11:00 CST 2012, time=2012-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264444, encodeId=1d811264444f9, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1922, encryptionId=150f19229c, topicName=ADA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Thu Jun 21 10:11:00 CST 2012, time=2012-06-21, status=1, ipAttribution=)]
    2012-06-21 般若傻瓜

相关资讯

ADA/EASD糖尿病高血糖管理声明

  2型糖尿病的血糖管理已日趋复杂并伴随争议,随着可用药物的不断增多,有关药物潜在不良反应的担忧及强化血糖控制对于大血管并发症益处的不确定性不断增加。很多医生在为患者制定最佳策略时感到困惑。   为此,美国糖尿病学会(ADA)和欧洲糖尿病研究学会(EASD)召集了一个联合工作组,检验了证据并提出了非妊娠成人2型糖尿病患者降糖治疗的建议。ADA和EASD及其他学会和组织已经发布过几个相关的指南文件

ADA糖尿病指南更新三要点

 2011年初,美国糖尿病学会(ADA)按照惯例再度更新了糖尿病诊疗指南[Diabetes Care 2011, 34(Suppl 1): S1],为临床实践提供了与时俱进的建议。虽然与2010版指南公布仅相隔1年,但新版指南仍有部分更新要点值得总结。   更新点1 妊娠糖尿病筛查及诊断标准更严格   肥胖和糖尿病的持续流行使更多育龄妇女罹患2

ADA/EASD 2012年糖尿病指南解读和下载

  美国糖尿病学会(ADA,American Diabetes Association)和欧洲糖尿病研究协会(EASD,European Association for the Study of Diabetes)发表有关2型糖尿病治疗的最新立场声明,强调以患者为中心的治疗。      新指南的主要建议:   ? 必须根据患者具体特点制定个体化的血糖目标和降血糖治疗方

ADA官方杂志精选中文版近期出版

  美国糖尿病学会(ADA)出版有《糖尿病》(Diabetes)、《糖尿病护理》(Diabetes Care)、《临床糖尿病》(Clinical Diabetes)和《糖尿病谱》(Diabetes Spectrum)4本官方杂志,近日ADA首次为中国糖尿病学界设立上述杂志精选中文版《American Diabetes Association Journals In Focus》,以向我国传播和介绍